A carregar...
Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion
Introduction: Denosumab, a fully human monoclonal antibody, targets the receptor activator of nuclear factor-kappaB (RANK) ligand, a protein essential for osteoclast differentiation, activity and survival. Loss of osteoclasts from the bone surface reduces bone turnover and bone loss in malignant and...
Na minha lista:
Main Authors: | , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
SAGE Publications
2011
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3169928/ https://ncbi.nlm.nih.gov/pubmed/21957430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834011412656 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|